Federal Court permits lawsuit against Dentsply Sirona regarding Byte Aligner business to move forward

A recent ruling by a US District Court has allowed a securities fraud class-action lawsuit against Dentsply Sirona to move forward. The lawsuit alleges that the company misled investors regarding its Byte direct-to-consumer clear aligner business. Specifically, the lawsuit claims that Dentsply Sirona misrepresented the level of doctor involvement in treatment and failed to report thousands of patient injuries to the FDA.

One of the key points of contention in the lawsuit is the alleged lack of doctor oversight in Byte treatments. Plaintiffs argue that the company falsely marketed Byte aligners as “doctor-directed” and claimed that doctors oversaw every step of the treatment process. However, according to court documents, patient treatment plans were actually created by non-dentist treatment planners in Costa Rica. These plans were then sent to US-based dentists for approval through a quick process that did not involve substantial input from the dentists. The complaint also alleges that patient care was managed by customer service employees and dental assistants, who were not authorized to allow patients to speak with licensed dentists.

Another serious accusation in the lawsuit is the failure of Dentsply Sirona to report adverse events to the FDA in a timely manner. The complaint states that the company tracked thousands of serious patient injuries in an internal database but did not disclose them to the FDA. In fact, it is alleged that 97% of these injuries were not reported until much later, despite occurring as far back as December 2023. The injuries reportedly included issues such as tooth fractures, lacerations, and necrosis. Dentsply Sirona only began retroactively reporting these injuries in February 2024, and eventually suspended sales of Byte aligners in October 2024 before completely shutting down the business in February 2025.

The court’s ruling has allowed the case to proceed against most of the company’s executives, including the former CEO and the current CEO. It was found that there were sufficient allegations to suggest that these executives had access to information that contradicted their public statements about Byte aligners. Additionally, the departure of three senior executives in mid-2024, coinciding with the emergence of injury reporting issues, has raised suspicions of wrongdoing.

Overall, the court’s decision represents a significant development in the legal battle against Dentsply Sirona over its Byte aligner business. The allegations of insufficient doctor oversight and failure to report patient injuries have serious implications for the company and its executives, and the case is likely to continue to attract attention as it progresses.